Author: Arlandis Salvador
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.32, Iss.8, 2012-08, pp. : 523-532
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations
Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. :
Vulnerable Elderly Patients and Overactive Bladder Syndrome
Drugs & Aging, Vol. 27, Iss. 9, 2010-09 ,pp. :
Transdermal Oxybutynin: For Overactive Bladder
By Bang L.M. Easthope S.E. Perry C.M.
Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. :
Solifenacin in Overactive Bladder Syndrome
Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. :